Abstract

It has become clear that diffuse large B-cell lymphoma is not a uniform antibody. Several recognizable variants have clinically distinct features and, frequently, require specific treatment approaches. Recognition of these variants and utilization of the appropriate treatments will improve the outcome for the patients.

Original languageEnglish (US)
Pages (from-to)27-30
Number of pages4
JournalTransfusion and Apheresis Science
Volume49
Issue number1
DOIs
StatePublished - Aug 1 2013

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Antibodies
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

Clinically important variants of diffuse large B-cell lymphoma. / Armitage, James Olen.

In: Transfusion and Apheresis Science, Vol. 49, No. 1, 01.08.2013, p. 27-30.

Research output: Contribution to journalArticle

@article{48bc81f2b6464fbaaa515bbda5ae8ff3,
title = "Clinically important variants of diffuse large B-cell lymphoma",
abstract = "It has become clear that diffuse large B-cell lymphoma is not a uniform antibody. Several recognizable variants have clinically distinct features and, frequently, require specific treatment approaches. Recognition of these variants and utilization of the appropriate treatments will improve the outcome for the patients.",
author = "Armitage, {James Olen}",
year = "2013",
month = "8",
day = "1",
doi = "10.1016/j.transci.2013.05.021",
language = "English (US)",
volume = "49",
pages = "27--30",
journal = "Transfusion and Apheresis Science",
issn = "1473-0502",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Clinically important variants of diffuse large B-cell lymphoma

AU - Armitage, James Olen

PY - 2013/8/1

Y1 - 2013/8/1

N2 - It has become clear that diffuse large B-cell lymphoma is not a uniform antibody. Several recognizable variants have clinically distinct features and, frequently, require specific treatment approaches. Recognition of these variants and utilization of the appropriate treatments will improve the outcome for the patients.

AB - It has become clear that diffuse large B-cell lymphoma is not a uniform antibody. Several recognizable variants have clinically distinct features and, frequently, require specific treatment approaches. Recognition of these variants and utilization of the appropriate treatments will improve the outcome for the patients.

UR - http://www.scopus.com/inward/record.url?scp=84882848051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882848051&partnerID=8YFLogxK

U2 - 10.1016/j.transci.2013.05.021

DO - 10.1016/j.transci.2013.05.021

M3 - Article

VL - 49

SP - 27

EP - 30

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

SN - 1473-0502

IS - 1

ER -